Free Trial

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Increases Stake in The Cooper Companies, Inc. $COO

Cooper Companies logo with Medical background

Key Points

  • UBS Asset Management increased its stake in The Cooper Companies by 15.5%, owning over 2.1 million shares valued at approximately $179 million as of the last quarter.
  • CEO Albert G. White III purchased 10,000 shares at an average cost of $68.39, raising his ownership to 226,151 shares, valued at approximately $15.47 million.
  • Cooper Companies reported a quarterly earnings of $1.10 per share, exceeding expectations, with revenue of $1.06 billion indicating a year-over-year growth of 5.7%.
  • Five stocks we like better than Cooper Companies.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 15.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,121,835 shares of the medical device company's stock after buying an additional 284,943 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned approximately 1.06% of Cooper Companies worth $178,977,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of COO. Captrust Financial Advisors boosted its position in shares of Cooper Companies by 19.0% in the fourth quarter. Captrust Financial Advisors now owns 4,542 shares of the medical device company's stock worth $418,000 after purchasing an additional 726 shares during the period. Cetera Investment Advisers raised its stake in Cooper Companies by 1.3% during the fourth quarter. Cetera Investment Advisers now owns 24,049 shares of the medical device company's stock valued at $2,211,000 after purchasing an additional 312 shares in the last quarter. Ethic Inc. raised its stake in Cooper Companies by 6.5% during the fourth quarter. Ethic Inc. now owns 8,524 shares of the medical device company's stock valued at $784,000 after purchasing an additional 517 shares in the last quarter. Gotham Asset Management LLC purchased a new stake in Cooper Companies during the fourth quarter valued at $530,000. Finally, Lighthouse Investment Partners LLC purchased a new stake in Cooper Companies during the fourth quarter valued at $919,000. 24.39% of the stock is currently owned by institutional investors.

Insider Activity

In other news, COO Daniel G. Mcbride purchased 3,000 shares of the stock in a transaction dated Tuesday, September 2nd. The shares were acquired at an average cost of $65.04 per share, for a total transaction of $195,120.00. Following the acquisition, the chief operating officer owned 63,120 shares of the company's stock, valued at approximately $4,105,324.80. This represents a 4.99% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Albert G. White III purchased 10,000 shares of the stock in a transaction dated Friday, September 5th. The stock was purchased at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the completion of the acquisition, the chief executive officer directly owned 226,151 shares in the company, valued at approximately $15,466,466.89. This represents a 4.63% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 15,975 shares of company stock valued at $1,079,566 over the last 90 days. 1.98% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $76.00 to $66.00 and set a "neutral" rating on the stock in a research note on Thursday, August 28th. Morgan Stanley set a $76.00 price target on shares of Cooper Companies and gave the company an "equal weight" rating in a research note on Thursday, August 28th. Mizuho decreased their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 16th. BNP Paribas raised shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, July 22nd. Finally, Piper Sandler reduced their target price on shares of Cooper Companies from $105.00 to $83.00 and set an "overweight" rating on the stock in a research note on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $86.64.

Get Our Latest Research Report on Cooper Companies

Cooper Companies Stock Down 0.0%

Cooper Companies stock traded down $0.02 during midday trading on Wednesday, hitting $65.14. 400,816 shares of the company's stock were exchanged, compared to its average volume of 2,294,836. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $112.29. The firm has a 50-day moving average of $71.19 and a two-hundred day moving average of $75.55. The company has a market cap of $12.95 billion, a PE ratio of 32.09, a P/E/G ratio of 1.72 and a beta of 0.97.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts' consensus estimates of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The business had revenue of $1.06 billion for the quarter, compared to analysts' expectations of $1.06 billion. During the same period last year, the business earned $0.96 EPS. The company's revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Read More

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.